Want to see TXG full AI Analyst Report?

10x Genomics (TXG) Stock Forecast & Price Target

1,271 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TXG Analyst Ratings

Moderate Buy

5 Buy

7 Hold

0 Sell

Based on 12 analysts giving stock ratings to

10x

Genomics

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TXG Stock 12 Month Forecast

Average Price Target

$47.70

▲(3.09% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for 10x Genomics in the last 3 months. The average price target is $47.70 with a high forecast of $60.00 and a low forecast of $40.00. The average price target represents a 3.09% change from the last price of $46.27.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","36":"$36","61":"$61","23.5":"$23.5","48.5":"$48.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$60.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":47.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$47.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,23.5,36,48.5,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.27,48.24923076923077,49.22846153846154,50.20769230769231,51.18692307692308,52.16615384615385,53.145384615384614,54.12461538461539,55.103846153846156,56.08307692307692,57.06230769230769,58.041538461538465,59.02076923076923,{"y":60,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.27,47.30307692307693,47.33615384615385,47.369230769230775,47.402307692307694,47.43538461538462,47.46846153846154,47.501538461538466,47.534615384615385,47.56769230769231,47.60076923076923,47.63384615384616,47.66692307692308,{"y":47.7,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.27,46.71076923076923,46.151538461538465,45.59230769230769,45.033076923076926,44.473846153846154,43.91461538461539,43.355384615384615,42.79615384615385,42.23692307692308,41.67769230769231,41.11846153846154,40.55923076923077,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.08,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.37,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.39,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.64,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.08,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.31,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.95,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.14,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.05,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.43,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.59,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.05,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.27,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$60.00

Average Price Target$47.70

Lowest Price Target$40.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Westenberg

Piper Sandler

$42→$47

Hold

1.58%

Upside

Reiterated

08/10/26

Piper Sandler Keeps Their Hold Rating on 10x Genomics (TXG)

Kyle Mikson CFA

Canaccord Genuity

$50→$60

Buy

29.67%

Upside

Reiterated

08/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Kallum Titchmarsh

Morgan Stanley

$40

Hold

-13.55%

Downside

Assigned

08/10/26

Analysts Offer Insights on Healthcare Companies: Zoetis (NYSE: ZTS), GoodRx Holdings (NASDAQ: GDRX) and 10x Genomics (NASDAQ: TXG)

Casey Woodring

J.P. Morgan

$38→$50

Hold

8.06%

Upside

Reiterated

08/10/26

J.P. Morgan Remains a Hold on 10x Genomics (TXG)

Matt Larew

William Blair

―

Buy

―

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (NASDAQ: VRCA) and 10x Genomics (NASDAQ: TXG)

Tycho Peterson

Jefferies

$53

Buy

14.55%

Upside

Reiterated

08/07/26

Analysts Are Bullish on These Healthcare Stocks: Becton Dickinson (BDX), 10x Genomics (TXG)

Daniel Arias

Stifel Nicolaus

$25→$50

Buy

8.06%

Upside

Reiterated

08/07/26

Stifel Nicolaus Sticks to Its Buy Rating for 10x Genomics (TXG)

Michael Ryskin

Bank of America Securities

―

Hold

―

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (NASDAQ: ARVN), 10x Genomics (NASDAQ: TXG) and Teleflex (NYSE: TFX)

Patrick B Donnelly

Citi

$45→$50

Hold

8.06%

Upside

Reiterated

08/07/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Haemonetics (NYSE: HAE), 10x Genomics (NASDAQ: TXG) and Scholar Rock Holding (NASDAQ: SRRK)

Puneet Souda

Leerink Partners

$23→$40

Hold

-13.55%

Downside

Reiterated

07/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: 10x Genomics (NASDAQ: TXG), Elevance Health (NYSE: ELV) and Johnson & Johnson (NYSE: JNJ)

Daniel Brennan

TD Cowen

$25→$47

Hold

1.58%

Upside

Reiterated

07/15/26

10x Genomics price target raised to $47 from $25 at TD Cowen10x Genomics price target raised to $47 from $25 at TD Cowen

Luke Sergott

Barclays

$30→$40

Buy

-13.55%

Downside

Assigned

06/24/26

Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)

Justin Bowers

Deutsche Bank

$17→$23

Hold

-50.29%

Downside

Reiterated

05/08/26

10x Genomics price target raised to $23 from $17 at Deutsche Bank10x Genomics price target raised to $23 from $17 at Deutsche Bank

Dan Leonard

RBC Capital

$14→$20

Hold

-56.78%

Downside

Reiterated

02/19/26

UBS Reaffirms Their Hold Rating on 10x Genomics (TXG)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Westenberg

Piper Sandler

$42→$47

Hold

1.58%

Upside

Reiterated

08/10/26

Piper Sandler Keeps Their Hold Rating on 10x Genomics (TXG)

Kyle Mikson CFA

Canaccord Genuity

$50→$60

Buy

29.67%

Upside

Reiterated

08/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Kallum Titchmarsh

Morgan Stanley

$40

Hold

-13.55%

Downside

Assigned

08/10/26

Analysts Offer Insights on Healthcare Companies: Zoetis (NYSE: ZTS), GoodRx Holdings (NASDAQ: GDRX) and 10x Genomics (NASDAQ: TXG)

Casey Woodring

J.P. Morgan

$38→$50

Hold

8.06%

Upside

Reiterated

08/10/26

J.P. Morgan Remains a Hold on 10x Genomics (TXG)

Matt Larew

William Blair

―

Buy

―

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (NASDAQ: VRCA) and 10x Genomics (NASDAQ: TXG)

Tycho Peterson

Jefferies

$53

Buy

14.55%

Upside

Reiterated

08/07/26

Analysts Are Bullish on These Healthcare Stocks: Becton Dickinson (BDX), 10x Genomics (TXG)

Daniel Arias

Stifel Nicolaus

$25→$50

Buy

8.06%

Upside

Reiterated

08/07/26

Stifel Nicolaus Sticks to Its Buy Rating for 10x Genomics (TXG)

Michael Ryskin

Bank of America Securities

―

Hold

―

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (NASDAQ: ARVN), 10x Genomics (NASDAQ: TXG) and Teleflex (NYSE: TFX)

Patrick B Donnelly

Citi

$45→$50

Hold

8.06%

Upside

Reiterated

08/07/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Haemonetics (NYSE: HAE), 10x Genomics (NASDAQ: TXG) and Scholar Rock Holding (NASDAQ: SRRK)

Puneet Souda

Leerink Partners

$23→$40

Hold

-13.55%

Downside

Reiterated

07/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: 10x Genomics (NASDAQ: TXG), Elevance Health (NYSE: ELV) and Johnson & Johnson (NYSE: JNJ)

Daniel Brennan

TD Cowen

$25→$47

Hold

1.58%

Upside

Reiterated

07/15/26

10x Genomics price target raised to $47 from $25 at TD Cowen10x Genomics price target raised to $47 from $25 at TD Cowen

Luke Sergott

Barclays

$30→$40

Buy

-13.55%

Downside

Assigned

06/24/26

Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)

Justin Bowers

Deutsche Bank

$17→$23

Hold

-50.29%

Downside

Reiterated

05/08/26

10x Genomics price target raised to $23 from $17 at Deutsche Bank10x Genomics price target raised to $23 from $17 at Deutsche Bank

Dan Leonard

RBC Capital

$14→$20

Hold

-56.78%

Downside

Reiterated

02/19/26

UBS Reaffirms Their Hold Rating on 10x Genomics (TXG)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

TNYATenaya Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering 10x Genomics

3 Months

Kyle Mikson CFACanaccord Genuity

Success Rate

16/27 ratings generated profit

Average Return

+11.90%

Copying Kyle Mikson CFA's trades and holding each position for 3 Months would result in 59.26% of your transactions generating a profit, with an average return of +11.90% per trade.

1 Year

Kyle Mikson CFACanaccord Genuity

Success Rate

15/27 ratings generated profit

Average Return

+71.67%

Copying Kyle Mikson CFA's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +71.67% per trade.

2 Years

Kyle Mikson CFACanaccord Genuity

Success Rate

18/27 ratings generated profit

Average Return

+130.87%

Copying Kyle Mikson CFA's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +130.87% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TXG Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TXG has received 9 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. TXG average Analyst price target in the past 3 months is 47.70.

Each month's total comprises the sum of three months' worth of ratings.

TXG Financial Forecast

TXG Earnings Forecast

Next quarter’s earnings estimate for TXG is -$0.27 with a range of -$0.34 to -$0.20. The previous quarter’s EPS was -$0.14. TXG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.51% of the time in the same period. In the last calendar year TXG has Performed in-line its overall industry.

TXG Sales Forecast

Next quarter’s sales forecast for TXG is $147.21M with a range of $146.20M to $148.76M. The previous quarter’s sales results were $151.04M. TXG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.92% of the time in the same period. In the last calendar year TXG has Performed in-line its overall industry.

TXG Stock Forecast FAQ

What is TXG’s average 12-month price target, according to analysts?

Based on analyst ratings, 10X Genomics’s 12-month average price target is 47.70.

What is TXG’s upside potential, based on the analysts’ average price target?

10X Genomics has 3.09% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TXG a Buy, Sell or Hold?

10X Genomics has a consensus rating of Moderate Buy which is based on 5 buy ratings, 7 hold ratings and 0 sell ratings.

What is 10X Genomics’s price target?

The average price target for 10X Genomics is 47.70. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $60.00 ,the lowest forecast is $40.00. The average price target represents 3.09% Increase from the current price of $46.27.

What do analysts say about 10X Genomics?

10X Genomics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of TXG?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

10x Genomics (TXG) Stock Forecast & Price Target

TXG Analyst Ratings

TXG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering 10x Genomics

TXG Analyst Recommendation Trends

TXG Financial Forecast

TXG Earnings Forecast

TXG Sales Forecast

TXG Stock Forecast FAQ

Detailed List of Analyst Forecasts